Lene Ryom email@example.com
Amanda Mocroft firstname.lastname@example.org
The goal of the outcomes SIG is to study outcomes amongst persons treated with ARVs. Two projects are approved by the SSC and have started preliminary analysis. The first is studying the uptake and discontinuation of integrase inhibitors (INSTIs) and looking at both shorter and longer term reasons for discontinuation. The second is looking at immunological and virologic response to those starting an INSTI compared to a contemporary non-INSTI regimen, and will be including clinical outcomes if there is sufficient data. A third project is under development, looking at the outcomes comparing those starting a 2-drug antiretroviral regimen compared with those starting a more traditional 3 drug antiretroviral regimen.